Here's the live share price of Aarti Pharmalabs along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Aarti Pharmalabs has gained 19.30% CAGR. Over the past year, the corresponding return has been 34.83%.
Aarti Pharmalabs’s current P/E of 31.01x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
---|---|---|---|---|---|---|---|
Aarti Pharmalabs | 1.17 | 16.94 | 6.20 | 17.70 | 37.34 | 34.20 | 19.30 |
Sun Pharmaceutical Industries | 1.08 | -1.32 | -2.30 | -5.58 | -13.67 | 22.86 | 25.44 |
Divi's Laboratories | 0.84 | -1.39 | -6.98 | 7.26 | 11.48 | 19.38 | 13.39 |
Cipla | -0.48 | -0.53 | 3.50 | 4.23 | -6.88 | 14.18 | 15.63 |
Torrent Pharmaceuticals | -1.63 | -3.25 | 8.69 | 15.50 | 2.40 | 33.75 | 19.96 |
Dr. Reddy's Laboratories | 0.49 | 3.70 | -0.64 | 13.92 | -1.18 | 17.09 | 7.19 |
Mankind Pharma | -1.56 | 3.97 | 9.17 | 18.23 | 4.67 | 21.72 | 12.52 |
Zydus Lifesciences | -0.55 | 4.77 | 7.79 | 15.71 | -6.91 | 42.05 | 21.62 |
Lupin | 3.72 | 4.15 | 5.54 | 3.02 | -9.66 | 48.04 | 14.81 |
Abbott India | -0.88 | -4.93 | -2.46 | 2.81 | 7.44 | 20.90 | 13.41 |
Alkem Laboratories | 3.56 | 3.02 | 14.49 | 14.40 | -11.41 | 20.01 | 14.29 |
Aurobindo Pharma | 3.96 | 0.18 | -1.58 | -1.88 | -29.64 | 26.95 | 5.60 |
Glenmark Pharmaceuticals | -2.57 | 5.17 | 25.57 | 45.12 | 21.20 | 77.31 | 32.95 |
Laurus Labs | -0.17 | 3.44 | 35.51 | 53.95 | 78.57 | 20.10 | 27.14 |
Biocon | -1.06 | -1.13 | 2.14 | 7.85 | -4.10 | 7.35 | -3.86 |
Anthem Biosciences | 1.87 | 3.75 | 13.75 | 13.75 | 13.75 | 4.39 | 2.61 |
GlaxoSmithKline Pharmaceuticals | -3.13 | -1.60 | -15.60 | 1.95 | -1.96 | 24.23 | 9.16 |
Cohance Lifesciences | -0.02 | 10.08 | -0.30 | -12.87 | -14.37 | 28.96 | 21.52 |
Gland Pharma | 6.20 | 2.52 | 15.71 | 30.13 | 9.43 | -4.11 | 2.12 |
Ipca Laboratories | -0.22 | -5.32 | -3.38 | -0.34 | -9.99 | 14.97 | 3.52 |
Over the last one year, Aarti Pharmalabs has gained 37.34% compared to peers like Sun Pharmaceutical Industries (-13.67%), Divi's Laboratories (11.48%), Cipla (-6.88%). From a 5 year perspective, Aarti Pharmalabs has outperformed peers relative to Sun Pharmaceutical Industries (25.44%) and Divi's Laboratories (13.39%).
Day | SMA | EMA |
---|---|---|
5 | 896.76 | 918.4 |
10 | 881.38 | 900.85 |
20 | 852.24 | 884.25 |
50 | 886.71 | 875.61 |
100 | 861.09 | 851.1 |
200 | 771.06 | 791.4 |
In the latest quarter, Aarti Pharmalabs saw a drop in promoter holding to 43.74%, while DII stake increased to 7.80%, FII holding fell to 7.34%, and public shareholding moved up to 41.12% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
---|---|---|---|
HDFC Multi Cap Fund | 4,28,834 | 0.2 | 36.08 |
HDFC Large and Mid Cap Fund - Regular Plan | 67,500 | 0.02 | 5.68 |
Axis Capital Builder Fund - Series 4 | 58,149 | 0.12 | 1.6 |
HSBC Mid Cap Fund - OLD | 50,000 | 0.1 | 1.11 |
L&T Focused Equity Fund | 40,001 | 0.1 | 0.98 |
Motilal Oswal BSE Healthcare ETF | 1,195 | 0.32 | 0.1 |
Date Time | Announcement |
---|---|
Sep 03, 2025, 7:55 PM IST | Aarti Pharmalabs - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
Aug 29, 2025, 4:04 PM IST | Aarti Pharmalabs - Notice Of 6Th Annual General Meeting |
Aug 29, 2025, 5:46 AM IST | Aarti Pharmalabs - Reg. 34 (1) Annual Report. |
Aug 29, 2025, 5:33 AM IST | Aarti Pharmalabs - Business Responsibility and Sustainability Reporting (BRSR) |
Aug 22, 2025, 1:11 AM IST | Aarti Pharmalabs - Intimation Regarding 100 Days Campaign - ''''Saksham Niveshak'' |
Aarti Pharmalabs Ltd. is a Public Limited Listed company incorporated on 22/11/2019 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24100GJ2019PLC110964 and registration number is 110964. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 1771.35 Cr. and Equity Capital is Rs. 45.32 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Aarti Pharmalabs is ₹911.55 as on Sep 16, 2025.
The Aarti Pharmalabs is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Aarti Pharmalabs is ₹8,262.40 Cr as on Sep 16, 2025.
Today’s highest and lowest price of Aarti Pharmalabs are ₹946.45 and ₹908.35.
The 52-week high/low is the highest and lowest price at which Aarti Pharmalabs stock has traded in the past 52-week or nearly a year. The 52-week high of Aarti Pharmalabs is ₹971.50 and 52-week low of Aarti Pharmalabs is ₹550.25 as on Sep 16, 2025.
The Aarti Pharmalabs has shown returns of -3.01% over the past day, 16.94% for the past month, 4.24% over 3 months, 34.83% over 1 year, 34.2% across 3 years, and 19.3% over 5 years.
P/E ratio of and PB ratio of Aarti Pharmalabs are 31.01 and 4.45 on Sep 16, 2025. While the company gives a dividend yield of 0.00 per annum.